Mortality associated with discordant responses to antiretroviral therapy in resource-constrained settings

Suely Hiromi Tuboi, Antonio Guilherme Pacheco, Lee H. Harrison, Roslyn A. Stone, Margaret May, Martin W G Brinkhof, François Dabis, Matthias Egger, Denis Nash, David Bangsberg, Paula Braitstein, Constantin Yiannoutsos, Robin Wood, Eduardo Sprinz, Mauro Schechter

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

OBJECTIVES: We assessed mortality associated with immunologic and virologic patterns of response at 6 months of highly active antiretroviral therapy (HAART) in HIV-infected individuals from resource-limited countries in Africa and South America. METHODS: Patients who initiated HAART between 1996 and 2007, aged 16 years or older, and had at least 1 measurement (HIV-1 RNA plasma viral load or CD4 cell count) at 6 months of therapy (3-9 month window) were included. Therapy response was categorized as complete, discordant (virologic only or immunologic only), and absent. Associations between 6-month response to therapy and all-cause mortality were assessed by Cox proportional hazards regression. Robust standard errors were calculated to account for intrasite correlation. RESULTS: A total of 7160 patients, corresponding to 15,107 person-years, were analyzed. In multivariable analysis adjusted for age at HAART initiation, baseline clinical stage and CD4 cell count, year of HAART initiation, clinic, occurrence of an AIDS-defining condition within the first 6 months of treatment, and discordant and absent responses were associated with increased risk of death. CONCLUSIONS: Similar to reports from high-income countries, discordant immunologic and virologic responses were associated with intermediate risk of death compared with complete and no response in this large cohort of HIV-1 patients from resource-limited countries. Our results support a recommendation for wider availability of plasma viral load testing to monitor antiretroviral therapy in these settings.

Original languageEnglish
Pages (from-to)70-77
Number of pages8
JournalJournal of Acquired Immune Deficiency Syndromes
Volume53
Issue number1
DOIs
StatePublished - Jan 2010

Fingerprint

Highly Active Antiretroviral Therapy
Mortality
CD4 Lymphocyte Count
Viral Load
HIV-1
Therapeutics
South America
Acquired Immunodeficiency Syndrome
HIV
RNA

Keywords

  • Antiretroviral therapy
  • CD4 lymphocyte count
  • Cohort
  • Highly active
  • Low-income population
  • Mortality
  • Treatment outcome
  • Viral load

ASJC Scopus subject areas

  • Infectious Diseases
  • Pharmacology (medical)

Cite this

Tuboi, S. H., Pacheco, A. G., Harrison, L. H., Stone, R. A., May, M., Brinkhof, M. W. G., ... Schechter, M. (2010). Mortality associated with discordant responses to antiretroviral therapy in resource-constrained settings. Journal of Acquired Immune Deficiency Syndromes, 53(1), 70-77. https://doi.org/10.1097/QAI.0b013e3181c22d19

Mortality associated with discordant responses to antiretroviral therapy in resource-constrained settings. / Tuboi, Suely Hiromi; Pacheco, Antonio Guilherme; Harrison, Lee H.; Stone, Roslyn A.; May, Margaret; Brinkhof, Martin W G; Dabis, François; Egger, Matthias; Nash, Denis; Bangsberg, David; Braitstein, Paula; Yiannoutsos, Constantin; Wood, Robin; Sprinz, Eduardo; Schechter, Mauro.

In: Journal of Acquired Immune Deficiency Syndromes, Vol. 53, No. 1, 01.2010, p. 70-77.

Research output: Contribution to journalArticle

Tuboi, SH, Pacheco, AG, Harrison, LH, Stone, RA, May, M, Brinkhof, MWG, Dabis, F, Egger, M, Nash, D, Bangsberg, D, Braitstein, P, Yiannoutsos, C, Wood, R, Sprinz, E & Schechter, M 2010, 'Mortality associated with discordant responses to antiretroviral therapy in resource-constrained settings', Journal of Acquired Immune Deficiency Syndromes, vol. 53, no. 1, pp. 70-77. https://doi.org/10.1097/QAI.0b013e3181c22d19
Tuboi, Suely Hiromi ; Pacheco, Antonio Guilherme ; Harrison, Lee H. ; Stone, Roslyn A. ; May, Margaret ; Brinkhof, Martin W G ; Dabis, François ; Egger, Matthias ; Nash, Denis ; Bangsberg, David ; Braitstein, Paula ; Yiannoutsos, Constantin ; Wood, Robin ; Sprinz, Eduardo ; Schechter, Mauro. / Mortality associated with discordant responses to antiretroviral therapy in resource-constrained settings. In: Journal of Acquired Immune Deficiency Syndromes. 2010 ; Vol. 53, No. 1. pp. 70-77.
@article{d7c22ad3fdcf42aab6938a8dbbb08c3b,
title = "Mortality associated with discordant responses to antiretroviral therapy in resource-constrained settings",
abstract = "OBJECTIVES: We assessed mortality associated with immunologic and virologic patterns of response at 6 months of highly active antiretroviral therapy (HAART) in HIV-infected individuals from resource-limited countries in Africa and South America. METHODS: Patients who initiated HAART between 1996 and 2007, aged 16 years or older, and had at least 1 measurement (HIV-1 RNA plasma viral load or CD4 cell count) at 6 months of therapy (3-9 month window) were included. Therapy response was categorized as complete, discordant (virologic only or immunologic only), and absent. Associations between 6-month response to therapy and all-cause mortality were assessed by Cox proportional hazards regression. Robust standard errors were calculated to account for intrasite correlation. RESULTS: A total of 7160 patients, corresponding to 15,107 person-years, were analyzed. In multivariable analysis adjusted for age at HAART initiation, baseline clinical stage and CD4 cell count, year of HAART initiation, clinic, occurrence of an AIDS-defining condition within the first 6 months of treatment, and discordant and absent responses were associated with increased risk of death. CONCLUSIONS: Similar to reports from high-income countries, discordant immunologic and virologic responses were associated with intermediate risk of death compared with complete and no response in this large cohort of HIV-1 patients from resource-limited countries. Our results support a recommendation for wider availability of plasma viral load testing to monitor antiretroviral therapy in these settings.",
keywords = "Antiretroviral therapy, CD4 lymphocyte count, Cohort, Highly active, Low-income population, Mortality, Treatment outcome, Viral load",
author = "Tuboi, {Suely Hiromi} and Pacheco, {Antonio Guilherme} and Harrison, {Lee H.} and Stone, {Roslyn A.} and Margaret May and Brinkhof, {Martin W G} and Fran{\cc}ois Dabis and Matthias Egger and Denis Nash and David Bangsberg and Paula Braitstein and Constantin Yiannoutsos and Robin Wood and Eduardo Sprinz and Mauro Schechter",
year = "2010",
month = "1",
doi = "10.1097/QAI.0b013e3181c22d19",
language = "English",
volume = "53",
pages = "70--77",
journal = "Journal of Acquired Immune Deficiency Syndromes",
issn = "1525-4135",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Mortality associated with discordant responses to antiretroviral therapy in resource-constrained settings

AU - Tuboi, Suely Hiromi

AU - Pacheco, Antonio Guilherme

AU - Harrison, Lee H.

AU - Stone, Roslyn A.

AU - May, Margaret

AU - Brinkhof, Martin W G

AU - Dabis, François

AU - Egger, Matthias

AU - Nash, Denis

AU - Bangsberg, David

AU - Braitstein, Paula

AU - Yiannoutsos, Constantin

AU - Wood, Robin

AU - Sprinz, Eduardo

AU - Schechter, Mauro

PY - 2010/1

Y1 - 2010/1

N2 - OBJECTIVES: We assessed mortality associated with immunologic and virologic patterns of response at 6 months of highly active antiretroviral therapy (HAART) in HIV-infected individuals from resource-limited countries in Africa and South America. METHODS: Patients who initiated HAART between 1996 and 2007, aged 16 years or older, and had at least 1 measurement (HIV-1 RNA plasma viral load or CD4 cell count) at 6 months of therapy (3-9 month window) were included. Therapy response was categorized as complete, discordant (virologic only or immunologic only), and absent. Associations between 6-month response to therapy and all-cause mortality were assessed by Cox proportional hazards regression. Robust standard errors were calculated to account for intrasite correlation. RESULTS: A total of 7160 patients, corresponding to 15,107 person-years, were analyzed. In multivariable analysis adjusted for age at HAART initiation, baseline clinical stage and CD4 cell count, year of HAART initiation, clinic, occurrence of an AIDS-defining condition within the first 6 months of treatment, and discordant and absent responses were associated with increased risk of death. CONCLUSIONS: Similar to reports from high-income countries, discordant immunologic and virologic responses were associated with intermediate risk of death compared with complete and no response in this large cohort of HIV-1 patients from resource-limited countries. Our results support a recommendation for wider availability of plasma viral load testing to monitor antiretroviral therapy in these settings.

AB - OBJECTIVES: We assessed mortality associated with immunologic and virologic patterns of response at 6 months of highly active antiretroviral therapy (HAART) in HIV-infected individuals from resource-limited countries in Africa and South America. METHODS: Patients who initiated HAART between 1996 and 2007, aged 16 years or older, and had at least 1 measurement (HIV-1 RNA plasma viral load or CD4 cell count) at 6 months of therapy (3-9 month window) were included. Therapy response was categorized as complete, discordant (virologic only or immunologic only), and absent. Associations between 6-month response to therapy and all-cause mortality were assessed by Cox proportional hazards regression. Robust standard errors were calculated to account for intrasite correlation. RESULTS: A total of 7160 patients, corresponding to 15,107 person-years, were analyzed. In multivariable analysis adjusted for age at HAART initiation, baseline clinical stage and CD4 cell count, year of HAART initiation, clinic, occurrence of an AIDS-defining condition within the first 6 months of treatment, and discordant and absent responses were associated with increased risk of death. CONCLUSIONS: Similar to reports from high-income countries, discordant immunologic and virologic responses were associated with intermediate risk of death compared with complete and no response in this large cohort of HIV-1 patients from resource-limited countries. Our results support a recommendation for wider availability of plasma viral load testing to monitor antiretroviral therapy in these settings.

KW - Antiretroviral therapy

KW - CD4 lymphocyte count

KW - Cohort

KW - Highly active

KW - Low-income population

KW - Mortality

KW - Treatment outcome

KW - Viral load

UR - http://www.scopus.com/inward/record.url?scp=74049160029&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=74049160029&partnerID=8YFLogxK

U2 - 10.1097/QAI.0b013e3181c22d19

DO - 10.1097/QAI.0b013e3181c22d19

M3 - Article

VL - 53

SP - 70

EP - 77

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

SN - 1525-4135

IS - 1

ER -